Adult Weight Gain and Adiposity-Related Cancers: A Dose-Response Meta-Analysis of Prospective Observational Studies
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Adiposity, measured by body mass index, is implicated in carcinogenesis. While adult weight gain has diverse advantages over body mass index in measuring adiposity, systematic reviews on adult weight gain in relation to adiposity-related cancers are lacking. METHODS: PubMed and Embase were searched through September 2014 for prospective observational studies investigating the relationship between adult weight gain and the risk of 10 adiposity-related cancers. Dose-response meta-analyses were performed using a random-effects model to estimate summary relative risk (RR) and 95% confidence interval (CI) for each cancer type. All statistical tests were two-sided. RESULTS: A total of 50 studies were included. For each 5kg increase in adult weight gain, the summary relative risk was 1.11 (95% CI = 1.08 to 1.13) for postmenopausal breast cancer among no- or low-hormone replacement therapy (HRT) users, 1.39 (95% CI = 1.29 to 1.49) and 1.09 (95% CI = 1.02 to 1.16) for postmenopausal endometrial cancer among HRT nonusers and users, respectively, 1.13 (95% CI = 1.03 to 1.23) for postmenopausal ovarian cancer among no or low HRT users, 1.09 (95% CI = 1.04 to 1.13) for colon cancer in men. The relative risk of kidney cancer comparing highest and lowest level of adult weight gain was 1.42 (95% CI = 1.11 to 1.81). Adult weight gain was unrelated to cancers of the breast (premenopausal women, postmenopausal HRT users), prostate, colon (women), pancreas, and thyroid. An increase in risk associated with adult weight gain for breast cancer was statistically significantly greater among postmenopausal women (P heterogeneity = .001) and HRT nonusers (P heterogeneity = .001); that for endometrial cancer was alike among HRT nonusers (P heterogeneity = .04). CONCLUSIONS: Avoiding adult weight gain itself may confer protection against certain types of cancers, particularly among HRT nonusers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Renehan, A. G., Tyson, M., Egger, M., Heller, R. F., & Zwahlen, M. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60269-x · Cited by 5,219
Kopelman, P. G. (2000) · Nature · doi:10.1038/35007508 · Cited by 4,795 · cited 1×
“Excess adiposity is a major contributor to chronic diseases including type 2 diabetes, cardiovascular diseases, and some types of cancer (2).”
BackgroundMethods for Trend Estimation from Summarized Dose-Response Data, with Applications to Meta-Analysis
Greenland, S., & Longnecker, M. P. (1992) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116237 · Cited by 2,353 · cited 1×
“For linear dose-response meta-analyses assuming a linear relationship between adult weight gain and cancer risk, the method described by Greenland and Longnecker (30) was used to calculate appropriate study-specific relative risks (linear slopes) and 95% confidence intervals from the relative risks and 95% confidence…”
MethodPostmenopausal Hormone Replacement Therapy: Scientific Review
Nelson, H. D., Humphrey, L. L., Nygren, P., Teutsch, S. M., & Allan, J. D. (2002) · JAMA · doi:10.1001/jama.288.7.872 · Cited by 990
Estrogen production and action
Nelson, L. R., & Bulun, S. E. (2001) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2001.117432 · Cited by 834
Obesity and cancer: the role of dysfunctional adipose tissue
van Kruijsdijk, R. C. M., van der Wall, E., & Visseren, F. L. J. (2009) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-09-0372 · Cited by 715 · cited 3×
“While the residual association could be because of biases such as confounding, if real, it suggests that estrogens may be the main contributing factor, but insulin and bioavailable IGF-I may play a role in mediating excess adiposity and EC risk among postmenopausal women.”
BackgroundLeisure-Time Physical Activity, Body Size, and Colon Cancer in Women
Martinez, M. E., Giovannucci, E., Spiegelman, D., Willett, W. C., Hunter, D. J., & Colditz, G. A. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.13.948 · Cited by 419
Self-citationTestosterone concentrations in diabetic and nondiabetic obese men
Dhindsa, S., Miller, M. G., McWhirter, C. L., Mager, D. E., Ghanim, H., Chaudhuri, A., & Dandona, P. (2010) · Diabetes Care · doi:10.2337/dc09-1649 · Cited by 352 · cited 1×
“Excess adiposity among men is associated with lower circulating concentrations of testosterone (93), which has been hypothesized to be associated with a decreased risk of localized PC but with an increased risk of advanced PC (94).”
BackgroundBody mass index, hormone replacement therapy, and endometrial cancer risk: A meta-analysis
Crosbie, E. J., Zwahlen, M., Kitchener, H. C., Egger, M., & Renehan, A. G. (2010) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-10-0832 · Cited by 321 · cited 1×
“Thus, the BMI-based dose-response meta-analyses were equivalent to suggesting an increase in risk by 4%, 28%, and 4%, per 5 kg of weight gain for postmenopausal BC, EC among HRT nonusers, and OC among HRT nonusers, respectively (6,9,14).”
MethodVisceral adiposity, insulin resistance and cancer risk
Donohoe, C. L., Doyle, S. L., & Reynolds, J. V. (2011) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-3-12 · Cited by 247
Research works printed but not linked: 81
- Larsson, 2007, The American Journal of Clinical Nutrition, 86, 556, 10.1093/ajcn/86.3.556 · DOI · Paper page
- 2012, Annals of Oncology, 23, 1665, 10.1093/annonc/mdr603 · DOI · Paper page
- 2012, 7, e51446, 10.1371/journal.pone.0051446 · DOI · Paper page
- Mathew, 2009, Asian Pacific journal of cancer prevention : APJCP, 10, 471
- Ildaphonse, 2009, Asian Pacific journal of cancer prevention : APJCP, 10, 279
- 2012, Annals of Oncology, 23, 843, 10.1093/annonc/mdr398 · DOI · Paper page
- Larsson, 2007, British Journal of Cancer, 96, 1457, 10.1038/sj.bjc.6603703 · DOI · Paper page
- 2011, Cancer Epidemiology Biomarkers & Prevention, 20, 464, 10.1158/1055-9965.EPI-10-1220 · DOI · Paper page
- 2013, Obesity, 21, 1923, 10.1002/oby.20318 · DOI · Paper page
- Ballard-Barbash, 1994, Cancer, 74, 1090, 10.1002/1097-0142(19940801)74:3+<1090::AID-CNCR2820741518>3.0.CO;2-X · DOI · Paper page
- Stroup, 2000, JAMA, 283, 2008, 10.1001/jama.283.15.2008 · DOI · Paper page
- 2012, American Journal of Epidemiology, 176, 1130, 10.1093/aje/kws192 · DOI · Paper page
- 2009, 6, 60, 10.1016/j.genm.2009.02.002 · DOI · Paper page
- Kaaks, 2002, Cancer Epidemiology Biomarkers & Prevention, 11, 1531
- 1998, JNCI Journal of the National Cancer Institute, 90, 814, 10.1093/jnci/90.11.814 · DOI · Paper page
- Ho, 2003, Reproductive biology and endocrinology [electronic resource] : RB&E, 1, 73, 10.1186/1477-7827-1-73 · DOI · Paper page
- White, 2012, International journal of cancer. Journal international du cancer, 131, E705, 10.1002/ijc.27373 · DOI
- Hamling, 2008, Statistics in medicine, 27, 954, 10.1002/sim.3013 · DOI · Paper page
- DerSimonian, 1986, Controlled clinical trials, 7, 177, 10.1016/0197-2456(86)90046-2 · DOI · Paper page
- Bagnardi, 2004, American Journal of Epidemiology, 159, 1077, 10.1093/aje/kwh142 · DOI · Paper page
- Higgins, 2002, Statistics in medicine, 21, 1539, 10.1002/sim.1186 · DOI · Paper page
- Higgins, 2003, BMJ, 327, 557, 10.1136/bmj.327.7414.557 · DOI · Paper page
- Kawai, 2010, British Journal of Cancer, 103, 1443, 10.1038/sj.bjc.6605885 · DOI
- van den Brandt, 1997, Cancer causes & control : CCC, 8, 39, 10.1023/A:1018479020716 · DOI
- Radimer, 2004, Nutrition and cancer, 49, 7, 10.1207/s15327914nc4901_2 · DOI
- Sweeney, 2004, American Journal of Epidemiology, 160, 868, 10.1093/aje/kwh276 · DOI · Paper page
- Breslow, 2001, Cancer Epidemiology Biomarkers & Prevention, 10, 805
- 2013, Cancer Epidemiology Biomarkers & Prevention, 22, 1409, 10.1158/1055-9965.EPI-13-0136 · DOI
- Feigelson, 2004, Cancer Epidemiology Biomarkers & Prevention, 13, 220, 10.1158/1055-9965.EPI-03-0301 · DOI · Paper page
- Palmer, 2007, Cancer Epidemiology Biomarkers & Prevention, 16, 1795, 10.1158/1055-9965.EPI-07-0336 · DOI · Paper page
- Lahmann, 2005, British Journal of Cancer, 93, 582, 10.1038/sj.bjc.6602763 · DOI
- Ahn, 2007, Archives of Internal Medicine, 167, 2091, 10.1001/archinte.167.19.2091 · DOI · Paper page
- Michels, 2012, International journal of cancer. Journal international du cancer, 130, 902, 10.1002/ijc.26069 · DOI
- Bassett, 2012, International journal of cancer. Journal international du cancer, 131, 1711, 10.1002/ijc.27414 · DOI
- Chamberlain, 2011, International journal of cancer. Journal international du cancer, 129, 1199, 10.1002/ijc.25739 · DOI
- 2007, Cancer Epidemiology Biomarkers & Prevention, 16, 63, 10.1158/1055-9965.EPI-06-0754 · DOI · Paper page
- 2007, American Journal of Epidemiology, 165, 1271, 10.1093/aje/kwm013 · DOI
- 2013, European journal of cancer (Oxford, England : 1990), 49, 3526, 10.1016/j.ejca.2013.06.021 · DOI
- 2010, Cancer Epidemiology Biomarkers & Prevention, 19, 2978, 10.1158/1055-9965.EPI-10-0543 · DOI · Paper page
- 2010, Cancer Epidemiology Biomarkers & Prevention, 19, 1511, 10.1158/1055-9965.EPI-09-0813 · DOI
- Canchola, 2010, Cancer causes & control : CCC, 21, 1407, 10.1007/s10552-010-9568-8 · DOI
- Chang, 2007, Cancer Epidemiology Biomarkers & Prevention, 16, 723, 10.1158/1055-9965.EPI-06-0675 · DOI · Paper page
- Friedenreich, 2007, Cancer causes & control : CCC, 18, 399, 10.1007/s10552-006-0113-8 · DOI · Paper page
- 2013, British Journal of Cancer, 109, 751, 10.1038/bjc.2013.384 · DOI · Paper page
- Canchola, 2010, Cancer causes & control : CCC, 21, 2241, 10.1007/s10552-010-9647-x · DOI
- Schouten, 2003, American Journal of Epidemiology, 157, 424, 10.1093/aje/kwf224 · DOI · Paper page
- Patel, 2005, Cancer Epidemiology Biomarkers & Prevention, 14, 459, 10.1158/1055-9965.EPI-04-0583 · DOI · Paper page
- Isaksson, 2002, International journal of cancer. Journal international du cancer, 98, 480, 10.1002/ijc.10256 · DOI · Paper page
- 2014, Breast cancer research and treatment, 145, 545, 10.1007/s10549-014-2973-z · DOI
- 2009, Cancer Epidemiology Biomarkers & Prevention, 18, 2413, 10.1158/1055-9965.EPI-09-0293 · doi:10.1158/1055-9965.epi-09-0293
- Wright, 2007, Cancer, 109, 675, 10.1002/cncr.22443 · DOI · Paper page
- Jonsson, 2003, International journal of cancer. Journal international du cancer, 106, 594, 10.1002/ijc.11266 · DOI · Paper page
- Giovannucci, 1997, Cancer Epidemiology Biomarkers & Prevention, 6, 557
- Larsson, 2006, European journal of cancer (Oxford, England : 1990), 42, 2590, 10.1016/j.ejca.2006.04.015 · DOI
- Lahmann, 2010, International journal of cancer. Journal international du cancer, 126, 2404, 10.1002/ijc.24952 · DOI · Paper page
- Fairfield, 2002, Obstetrics & Gynecology, 100, 288, 10.1016/S0029-7844(02)02053-7 · DOI · Paper page
- Johansen, 2009, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], 9, 677, 10.1159/000212088 · DOI
- Luo, 2008, British Journal of Cancer, 99, 527, 10.1038/sj.bjc.6604487 · DOI
- Kitahara, 2012, International journal of cancer. Journal international du cancer, 130, 1411, 10.1002/ijc.26161 · DOI
- Kabat, 2012, Cancer causes & control : CCC, 23, 421, 10.1007/s10552-011-9890-9 · DOI
- Iribarren, 2001, International journal of cancer. Journal international du cancer, 93, 745, 10.1002/ijc.1377 · DOI · Paper page
- 2008, American Journal of Epidemiology, 168, 268, 10.1093/aje/kwn122 · DOI · Paper page
- 2007, American Journal of Epidemiology, 166, 752, 10.1093/aje/kwm137 · DOI · Paper page
- Chlebowski, 2004, New England Journal of Medicine, 350, 991, 10.1056/NEJMoa032071 · DOI · Paper page
- Vrieling, 2010, Breast cancer research and treatment, 123, 641, 10.1007/s10549-010-1116-4 · DOI · Paper page
- Feigelson, 2006, Cancer, 107, 12, 10.1002/cncr.21965 · DOI
- Writing Group for the Women's Health Initiative In, 2002, JAMA, 288, 321, 10.1001/jama.288.3.321 · DOI · Paper page
- TOTH, 2000, Annals of the New York Academy of Sciences, 904, 502, 10.1111/j.1749-6632.2000.tb06506.x · DOI · Paper page
- Michels, 2006, Archives of Internal Medicine, 166, 2395, 10.1001/archinte.166.21.2395 · DOI · Paper page
- Potischman, 1996, JNCI Journal of the National Cancer Institute, 88, 756, 10.1093/jnci/88.11.756 · DOI · Paper page
- 2013, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 11, 419, 10.1016/j.cgh.2012.11.012 · DOI · Paper page
- Hsing, 2007, The American Journal of Clinical Nutrition, 86, 843S, 10.1093/ajcn/86.3.843S · DOI · Paper page
- 2007, Epidemiologic Reviews, 29, 88, 10.1093/epirev/mxm006 · DOI · Paper page
- 2014, American Journal of Epidemiology, 179, 1353, 10.1093/aje/kwu052 · DOI · Paper page
- Niedhammer, 2000, International journal of obesity, 24, 1111, 10.1038/sj.ijo.0801375 · DOI · Paper page
- STEVENS, 1990, American Journal of Epidemiology, 132, 1156, 10.1093/oxfordjournals.aje.a115758 · DOI · Paper page
- Perry, 1995, Epidemiology (Cambridge, Mass.), 6, 61, 10.1097/00001648-199501000-00012 · DOI · Paper page
- PALTA, 1982, American Journal of Epidemiology, 115, 223, 10.1093/oxfordjournals.aje.a113294 · DOI · Paper page
- 2011, JNCI Journal of the National Cancer Institute, 103, 1086, 10.1093/jnci/djr189 · DOI · Paper page
- Tamakoshi, 2003, International journal of obesity, 27, 247, 10.1038/sj.ijo.802195 · DOI
- Mozaffarian, 2011, New England Journal of Medicine, 364, 2392, 10.1056/NEJMoa1014296 · DOI · Paper page
Cited by
Mehta, L. S., Watson, K. E., Barac, A., Beckie, T. M., Bittner, V., Cruz-Flores, S., Dent, S., Kondapalli, L., Ky, B., Okwuosa, T., et al. (2018) · Circulation · doi:10.1161/cir.0000000000000556 · Cited by 848
Adiposity and cancer at major anatomical sites: umbrella review of the literature
Kyrgiou, M., Kalliala, I., Markozannes, G., Gunter, M. J., Paraskevaidis, E., Gabra, H., Martin-Hirsch, P., & Tsilidis, K. K. (2017) · BMJ · doi:10.1136/bmj.j477 · Cited by 803
Adiposity and cancer risk: new mechanistic insights from epidemiology
Renehan, A. G., Zwahlen, M., & Egger, M. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3967 · Cited by 654
The Intestinal Microbiome and Estrogen Receptor–Positive Female Breast Cancer
(2016) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djw029 · Cited by 523
Cancer and Heart Disease: Associations and Relations
de Boer, R. A., Meijers, W. C., van der Meer, P., & van Veldhuisen, D. J. (2019) · European Journal of Heart Failure · doi:10.1002/ejhf.1539 · Cited by 227
Metadata
- Venue
- JNCI: Journal of the National Cancer Institute
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-03
- Volume
- 107
- Issue
- 3
- ISSN
- 0027-8874 (ISSN-L)
- 1460-2105
- OpenAlex
- W4235403188
- Cited by
- 86
- References
- 11
- FWCI
- 1.59
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Adult Weight Gain and Adiposity-Related Cancers: A Dose-Response Meta-Analysis of Prospective Observational Studies. https://app.cochat.ai/papers/10.1093/jnci/dju428
- The paper
- Adult Weight Gain and Adiposity-Related Cancers: A Dose-Response Meta-Analysis of Prospective Observational Studies. (2015). JNCI: Journal of the National Cancer Institute. https://doi.org/10.1093/jnci/dju428
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.